Press release
Hospital/Clinical Laboratories to Dominate Infectious Disease Testing Market until 2026 | TechSci Research
Infectious Disease Testing Market - TechSci Research
According to TechSci Research report, “Global Infectious Disease Testing Market By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others), By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others), By End User (Hospital/Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others), By Region, Forecast & Opportunities, 2026”, global infectious disease testing market was valued at USD16753.39 million in 2020 and is anticipated to reach USD 27712.09 million in 2026 by registering a growing CAGR of 8.27%. Rising old age population is one of the major factors accounting for the growth of global infectious disease testing market. Moreover, increase in funding for research on infectious disease diagnostics is expected to bode well for the growth of global infectious disease testing market through 2026. In addition to this, rapid shift from centralized laboratories to decentralized point-of-care testing facilities, is positively influencing the growth of global infectious disease testing market in the years to come. Also, surging requirement for rapid diagnostic technique over current techniques due to long turnaround time are making headway for the growth of global infectious disease testing market. Along with this, supportive government funding is positively contributing to the market growth. However, there are some factors that might act as major impediments to the growth of global infectious disease testing market through 2026 such as rising healthcare costs and reimbursement concerns.
Browse 132 Figures spread through 110 Pages and an in-depth TOC on "Global Infectious Disease Testing Market"
https://www.techsciresearch.com/report/infectious-disease-testing-market/4695.html
Global infectious disease testing market can be segmented based on product and service, technology, disease, end user, company, and region. Considering the disease, the market is fragmented into Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others. The hepatitis segment dominated the global infectious disease testing market in terms of largest market share until 2020 and is further anticipated to hold its dominance during the forecast years as well which can be accredited to rising prevalence of hepatitis cases all across the globe. In addition to that increasing initiatives by government organizations towards hepatitis prevention is another major factor forecast to contribute to the segmental growth over the coming years. In terms of end user, the market is fragmented into hospital/clinical laboratories, diagnostic reference laboratories, academic/research institutes, and others. Out of which, the hospital/clinical laboratories segment held the largest market share in 2020 and is further predicted to maintain its leading position during the forecast years as well on account of the fact that hospital laboratories are more accessible when compared to reference laboratories and offer test results quickly. Furthermore, increase in medicare reimbursement for clinical tests which are being done in hospitals is another key factor augmenting the demand for the segment over the years to come.
Abbott Laboratories, Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corporation, DiaSorin S.p.A., Meridian Bioscience Inc., Quidel Corporation, Siemens AG, Thermo Fisher Scientific Inc., Johnson and Johnson, F. Hoffmann-La Roche Ltd., Cepheid Inc., Qiagen N.V., OraSure Technologies, Inc., are among others are the leading players operating in global infectious disease testing market. The market players are adopting several growth strategies to enhance infectious disease testing market. Other competitive strategies include product launches; mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diverse their product portfolio in order to strengthen their market position.
Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4695
Customers can also request for 10% free customization on this report.
“North America is forecast to dominate the global infectious disease testing market during the next five years on account of presence of an advanced healthcare facility in the region. Furthermore, growing investments in the healthcare sector coupled with growing demand for point-of-care testing is also contributing to the growing trend. Additionally, existence of several leading national clinical laboratories is expected to further boost the market growth in region over the coming years. The Asia Pacific region is estimated to exhibit the fastest growth during the forecast period which can be accredited to the presence of developing economies such as China and India that have a high prevalence of infectious diseases.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Infectious Disease Testing Market By Product & Service (Assays, Kits, & Reagents; Instruments; Services & Software), By Technology (Molecular Diagnostics, Immunoassay, Microbiology, Others), By Disease (Hepatitis, Human Papillomavirus (HPV), Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Hospital-Acquired Infections (HAIs), Others), By End User (Hospital/Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Others), By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of global infectious disease testing market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global infectious disease testing market.
Browse Related Reports:
Global Clinical Diagnostics Market By Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial Resistance, HAIs, Others), Cardiovascular Emergencies, Personalized Medicine, Others(Industrial Applications (Agri-food sector, Biopharma, Cosmetics)), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, Academic & Medical Schools, Others), By Region, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/clinical-diagnostics-market/4519.html
Global Autoimmune Disease Diagnostics Market By Type (Systemic, Organ-Specific), By Sex (Male, Female), By Age (0-15, 15-44, 44+), By Factors (Diet, Genetics, Environmental agents), By Diagnosis (Antinuclear Antibody Test, Autoantibody Test, Others), By Types of Treatment (Nonsteroidal Anti-Inflammatory Drugs, Immune-Suppressing Drugs, Others), By Product (Kits and assays, Reagents), By End-User (Hospital, Clinics, Others), By Region, Competition, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/autoimmune-disease-diagnostics-market/4544.html
About TechSci Research:
TechSci Research is a leading global market research firm publishing premium market research reports. Serving 700 global clients with more than 600 premium market research studies, TechSci Research is serving clients across 11 different industrial verticals. TechSci Research specializes in research-based consulting assignments in high growth and emerging markets, leading technologies and niche applications. Our workforce of more than 100 fulltime Analysts and Consultants employing innovative research solutions and tracking global and country specific high growth markets helps TechSci clients to lead rather than follow market trends.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
Website: https://www.techsciresearch.com/
For More Market Research Blogs Visit: https://techsciblog.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Hospital/Clinical Laboratories to Dominate Infectious Disease Testing Market until 2026 | TechSci Research here
News-ID: 2299067 • Views: …
More Releases from TechSci Research Pvt Ltd
India AI in Medical Diagnostics Market Future Outlook (2024-2030)
India AI in Medical Diagnostics Market Outlook
The India AI in Medical Diagnostics Market, valued at USD 12.87 million in 2024, is poised for significant growth, with a projected compound annual growth rate (CAGR) of 23.10% from 2020 to 2030, reaching an estimated USD 44.87 million by 2030. This robust expansion is driven by the increasing adoption of artificial intelligence (AI) solutions in healthcare, a rising demand for early and accurate…
The Future of Robotic Healthcare Market in India
India Surgical Robotics Market Outlook
The India Surgical Robotics Market, valued at USD 24.72 million in 2024, is on a trajectory of significant growth, projected to reach USD 44.91 million by 2030, driven by a robust compound annual growth rate (CAGR) of 10.42%. This expansion is underpinned by a confluence of factors, including the rising demand for minimally invasive surgeries, advancements in robotic technologies, and the rapid development of healthcare infrastructure…
India Medical Lasers Market: Growth, Trends, and Challenges (2020-2030)
The India Medical Lasers Market is poised for significant growth, projected to expand at a compound annual growth rate (CAGR) of 12.90%, rising from USD 31.20 million in 2024 to USD 64.75 million by 2030. This robust growth is driven by increasing demand for minimally invasive procedures, a rising prevalence of chronic diseases, and supportive government initiatives such as Ayushman Bharat and Make in India. These programs are enhancing healthcare…
India Pneumococcal Vaccine Market Report Outlook 2030 by TechSci Research
Market Outlook: India Pneumococcal Vaccine Market
The India pneumococcal vaccine market is projected to grow from USD 32.52 million in 2024 to USD 48.67 million by 2030, reflecting a CAGR of 6.91%. Growth is being driven by strong government initiatives, such as the inclusion of the Pneumococcal Conjugate Vaccine (PCV) in the Universal Immunization Programme (UIP), rising awareness about pneumonia-related mortality-especially in children-and enhanced local production by domestic manufacturers.
Support from international…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
